Processa Pharmaceuticals Inc. Common Stock (PCSA)

About PCSA

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells. Its oncology pip…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

12

Website

www.processapharmaceuticals.com/

Fundamentals

1-day range

$2.11$2.18

Market cap

$7.65M

P/E (trailing)

3.31

P/E (forward)

-0.57

EPS (trailing)

$-10.90

Dividend yield

—

Beta

1.24

Avg. volume

249.0K

Dividend pay date

December 23, 2019

Processa Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• PCSA

  Processa Pharmaceuticals Inc. Common Stock

  $2.07

  ▼ 1.90%
  Market cap $7.65MP/E 3.31
  $1.67$14.24
• CNSP

  CNS Pharmaceuticals Inc. Common Stock

  $5.52

  ▲ 0.11%
  Market cap $7.65MP/E —
  $1.9$10.59
• MTVA

  MetaVia Inc. Common Stock

  $1.71

  ▲ 3.01%
  Market cap $7.49MP/E —
  $0.9661$19.03
• APRE

  Aprea Therapeutics Inc. Common stock

  $0.8387

  ▼ 2.48%
  Market cap $7.83MP/E —
  $0.548$1.69
• APUS

  Apimeds Pharmaceuticals US Inc. Common Stock

  $3.87

  ▼ 1.28%
  Market cap $7.29MP/E —
  $3.39$403.1
• SNGX

  Soligenix Inc. Common Stock

  $0.38

  ▲ 0.00%
  Market cap $8.24MP/E —
  $0.28$3.22
• XCUR

  Exicure Inc. Common Stock

  $1.34

  ▼ 5.32%
  Market cap $8.60MP/E —
  $1.05$9.48

P/E shows — for peers not currently carrying a live signal of their own.

• Sheila Gujrathi · July 28, 2026 · Grant

  12.3K
• Sheila Gujrathi · July 28, 2026 · Grant

  70.8K
• Geraldine Pannu · July 26, 2026 · Grant

  33.5K
• George K. Ng · July 26, 2026 · Grant

  9.4K
• James R. Neal · July 26, 2026 · Grant

  62.2K
• Patrick Lin · July 26, 2026 · Grant

  8.4K
• Wendy Guy · July 26, 2026 · Grant

  9.4K
• Khoso Baluch · July 26, 2026 · Grant

  33.5K
• Justin W. Yorke · July 26, 2026 · Grant

  33.5K
• Russell Skibsted · July 26, 2026 · Grant

  11.9K
• George K. Ng · July 1, 2026 · Buy

  3.1K @ $1.93
• Wendy Guy · June 30, 2026 · Buy

  2.4K @ $1.93
• Patrick Lin · June 30, 2026 · Buy

  2.1K @ $1.93
• David Young · June 30, 2026 · Buy

  2.5K @ $1.93
• Russell Skibsted · June 30, 2026 · Buy

  3.3K @ $1.93

Institutional Ownership

March 31, 2026

Total shares held

166.8K

Total value held

$421.1K

Institutional holders

9